Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
113,447,640
-
Share change
-
-1,585,147
-
Total reported value
-
$31,700,051,759
-
Put/Call ratio
-
99%
-
Price per share
-
$279.75
-
Number of holders
-
1,078
-
Value change
-
-$397,782,972
-
Number of buys
-
460
-
Number of sells
-
492
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2021
As of 31 Mar 2021,
BIOGEN INC. - COM (BIIB) was held by
1,078 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,447,640 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
1,085
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.